Clinical trials are fragile. Supply chain disruptions like cold chain failures or single-source dependencies threaten patient safety and trial success.
- U.S. Pharma Tariffs And MFN Become Law After April 2 Update
- 6 Risks To Clinical Supply Spurred By 'Once In A Lifetime' Lp(a) Screening
- Where Trial Budgets And Supply Plans Go Off Track — Earlier Than You Think
- From Policy To Practice: Embedding Export Compliance In Clinical Supply
- What CAPAs Don't Catch: 3 Hidden ATMP Cold Chain Vulnerabilities By Design
- AI And Digital Tools Advance Clinical Trial Supply Chains
- Solving Pharmacy And Clinical Supply Challenges In Decentralized Trials
- How The Strait Of Hormuz Crisis Is Stalling U.S. Medical Breakthroughs
ON-DEMAND WEBINARS
Achieving supply chain resilience is crucial, and flexible distribution strategies and ready-to-use depot and logistics networks are instrumental in establishing limitless flexibility and expertise capable of identifying possible risks.
See how study characteristics, regulatory landscapes, and business priorities combine to inform clinical supply placement decisions between EU and non-EU European locations.
Gain essential insights into QP roles, regulatory updates, and best practices for ensuring compliance, supply continuity, and safe handling of cold and frozen pharmaceutical products across the UK and EU.
Gain insights into managing global trial complexity, balancing accelerated timelines with compliance, using advanced technologies to improve efficiency, and leveraging partnerships to support seamless clinical operations.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-980809416 clinical supply]( "Enhancing Clinical IP Efficiency & Compliance")
Enhancing Clinical IP Efficiency & ComplianceA U.S.-based clinical research sponsor optimized their supply chain visibility, reduced costs and risks, and improved efficiency by replacing their manual inventory management system.
-
![GettyImages-1467240751 patient doctor]( "Delivering Apheresis Treatment From The USA To The UK Within 24 Hours")
Delivering Apheresis Treatment From The USA To The UK Within 24 HoursThe goal was to perform next-day collection of temperature-sensitive tumor material for an urgent patient treatment. A flexible mitigation strategy was essential to manage short turnaround.
-
![GettyImages-1425605790 Life Sciences Training. Scientists Using A Computer In A Lab]( "Treating Deficiencies In Employee Training And Mentorship")
Treating Deficiencies In Employee Training And MentorshipInvesting in employee training and development is not just beneficial for the employees. It also contributes significantly to the organization’s success and competitive advantage.
-
![clinical-trial-packaging-GettyImages-1417392283]( "The Critical Role Of Clinical Trial Packaging Services In Trial Success")
The Critical Role Of Clinical Trial Packaging Services In Trial SuccessCompliant, accurate packaging protects product integrity, supports dosing consistency, and keeps studies running smoothly. Smart components and controlled processes lower risk across complex trials.
-
![clinical-supply-GettyImages-1413600685]( "Building Clinical Supply Agility In A Changing Trial Landscape")
Building Clinical Supply Agility In A Changing Trial LandscapeRising trial complexity demands agile supply built on integrated operations, solid planning, and fast issue resolution. Lean teams gain from partners providing flexibility, control, and global reach.
-
![GettyImages-2174865907 workflow, lab, cell therapy]( "Tech Transfer Strategies For mAb Drug Products In Late-Phase Launch")
Tech Transfer Strategies For mAb Drug Products In Late-Phase LaunchTech transfer is not just a process of replicating manufacturing steps; it is a complex, multidisciplinary effort that ensures process robustness, scalability, regulatory compliance, and supply chain readiness.
-
![7 Seven Tips GettyImages-1450702003]( "7 Key Considerations For Designing The Optimal IRT/RTSM")
7 Key Considerations For Designing The Optimal IRT/RTSMSponsors can create IRT/RTSM systems that are not only efficient and reliable but also adaptable to the evolving needs of clinical research by focusing on these seven key considerations.
-
![GettyImages-1156884561-fill-finish]( "Key Considerations For Selecting Flexible Fillers")
Key Considerations For Selecting Flexible FillersFlexible fillers are beneficial to drug developers looking for lifecycle management of their drug products. Explore key considerations for selecting flexible fill/finish manufacturing technologies.
-
![West]( "Vial Containment Systems For Gene And Cell Therapies")
Vial Containment Systems For Gene And Cell TherapiesCZ vial-stopper-seal combinations offer a viable solution for the challenges associated with low-temperature storage of cell therapy drug products.
-
![GettyImages-1078167682-brexit-uk-ireland-eu]( "Understanding Post-BREXIT Regulatory Changes Impacting the Clinical Trial Supply Chain")
Understanding Post-BREXIT Regulatory Changes Impacting the Clinical Trial Supply ChainWith many BREXIT provisions now in effect and more to come, supply chains serving clinical trials in the UK and/or EU member states must navigate a complex web of new regulations.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
